Skin carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
|
10496530 |
1999 |
Acute lymphocytic leukemia
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Here, we investigated the mutual expression of the Survivin/EPR-1 genes in 12 normal peripheral blood (PB) specimens, seven normal bone marrow (BM) specimens, five lymph node (LN) specimens, and seven leukemic cell lines, and 27 patients with malignant lymphoma (ML), four with acute lymphocytic leukemia (ALL), three with acute myelocytic leukemia (AML), and four with chronic myelocytic leukemia in blastic crisis (CML-BC).
|
11086180 |
2000 |
Lymphoma
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Here, we investigated the mutual expression of the Survivin/EPR-1 genes in 12 normal peripheral blood (PB) specimens, seven normal bone marrow (BM) specimens, five lymph node (LN) specimens, and seven leukemic cell lines, and 27 patients with malignant lymphoma (ML), four with acute lymphocytic leukemia (ALL), three with acute myelocytic leukemia (AML), and four with chronic myelocytic leukemia in blastic crisis (CML-BC).
|
11086180 |
2000 |
Leukemia, Myelocytic, Acute
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Here, we investigated the mutual expression of the Survivin/EPR-1 genes in 12 normal peripheral blood (PB) specimens, seven normal bone marrow (BM) specimens, five lymph node (LN) specimens, and seven leukemic cell lines, and 27 patients with malignant lymphoma (ML), four with acute lymphocytic leukemia (ALL), three with acute myelocytic leukemia (AML), and four with chronic myelocytic leukemia in blastic crisis (CML-BC).
|
11086180 |
2000 |
Diffuse Large B-Cell Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Adult Diffuse Large B-Cell Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Hodgkin Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Nodular Sclerosis Classical Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Adult Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Childhood Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Hematologic Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
|
11086180 |
2000 |
Lewy Body Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
No EPR-1 expression with or without Survivin expression was clearly detected in eight of the nine diffuse large B-cell lymphoma (DLB) specimens, two of the six follicular center lymphoma specimens, one of the four specimens of nodular sclerosis of Hodgkin's lymphoma, two of the four ALL specimens or one of the four CML-BC specimens.
|
11086180 |
2000 |
Squamous cell carcinoma
|
0.390 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the potential expression and prognostic significance of the apoptosis inhibitor survivin in squamous cell carcinoma (SCC).
|
11418003 |
2001 |
Colorectal Carcinoma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Infection with pAd-T34A caused spontaneous apoptosis in cell lines of breast, cervical, prostate, lung, and colorectal cancer.
|
11581299 |
2001 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Tumors injected with pAd-T34A exhibited loss of proliferating cells and massive apoptosis by in situ internucleosomal DNA fragmentation.
|
11581299 |
2001 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A role of apoptosis (programmed cell death) in tumor formation and growth was investigated by targeting the apoptosis inhibitor survivin in vivo.
|
11149963 |
2001 |
Malignant neoplasm of colon and/or rectum
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Infection with pAd-T34A caused spontaneous apoptosis in cell lines of breast, cervical, prostate, lung, and colorectal cancer.
|
11581299 |
2001 |
Liver carcinoma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
|
12374680 |
2002 |
Squamous cell carcinoma
|
0.390 |
AlteredExpression
|
disease |
LHGDN |
Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications.
|
12174930 |
2002 |
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Increased expression of survivin in gastric cancer patients and in first degree relatives.
|
12085263 |
2002 |
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.
|
11773702 |
2002 |
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
|
12168867 |
2002 |
Renal Cell Carcinoma
|
0.340 |
AlteredExpression
|
disease |
LHGDN |
Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
|
12115583 |
2002 |
Glioma
|
0.250 |
AlteredExpression
|
disease |
LHGDN |
Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
|
11844831 |
2002 |
Neuroblastoma
|
0.070 |
Biomarker
|
disease |
LHGDN |
The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma.
|
11877677 |
2002 |